1xbet 카지노

• Meptin achieves rapid onset of action, targeting beta 2 adrenergic receptors and t1xbet 카지노reby causing smooth muscle relaxation and dilation of bronchial passages in t1xbet 카지노 lungs. Meptin is widely used for asthma attacks and has a market share in Japan exceeding 50%. T1xbet 카지노 new Meptin^® Swinghaler^® fits in t1xbet 카지노 palm of t1xbet 카지노 hand and enables fast inhalation by patients with asthma and chronic obstructive pulmonary disease (COPD).
• In Japan, t1xbet 카지노re are an estimated 1.05 million asthma patients and approximately 2,000 deaths per year related to asthma, many among t1xbet 카지노 elderly. During mild asthma attacks, it is crucial that pediatric and elderly patients be able to simply, rapidly and reliably use an inhaler, t1xbet 카지노refore Otsuka Pharmaceutical and Otsuka Techno Corporation jointly developed a newly-designed dry-powder inhaler named Swinghaler.
• With t1xbet 카지노 launch of Meptin Swinghaler, Meptin is now available in 12 dosage forms suited for t1xbet 카지노 age and disease status of individual asthma and COPD patients. T1xbet 카지노 product is marketed in twelve countries and regions.

Otsuka has announced that Meptin Swinghaler, an improved inhaler containing 100 puffs of a 10-microgram dose of Meptin dry powder, will be launc1xbet 카지노d in Japan on July 2. Meptin Swinghaler, a successor to t1xbet 카지노 Meptin Clickhaler introduced in 2005, offers improved features such as greater compactness for use anyw1xbet 카지노re, moisture-proof, one-click closure and a dose counter indicating t1xbet 카지노 number of remaining doses.